These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 12688391)

  • 21. Serum cortisol as a useful predictor of cardiac events in patients with chronic heart failure: the impact of oxidative stress.
    Yamaji M; Tsutamoto T; Kawahara C; Nishiyama K; Yamamoto T; Fujii M; Horie M
    Circ Heart Fail; 2009 Nov; 2(6):608-15. PubMed ID: 19919986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of the history of congestive heart failure on the utility of B-type natriuretic peptide in the emergency diagnosis of heart failure: results from the Breathing Not Properly Multinational Study.
    Strunk A; Bhalla V; Clopton P; Nowak RM; McCord J; Hollander JE; Duc P; Storrow AB; Abraham WT; Wu AH; Steg G; Perez A; Kazanegra R; Herrmann HC; Aumont MC; McCullough PA; Maisel A
    Am J Med; 2006 Jan; 119(1):69.e1-11. PubMed ID: 16431187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of spironolactone on electrical and structural remodeling of atrium in congestive heart failure dogs.
    Yang SS; Han W; Zhou HY; Dong G; Wang BC; Huo H; Wei N; Cao Y; Zhou G; Xiu CH; Li WM
    Chin Med J (Engl); 2008 Jan; 121(1):38-42. PubMed ID: 18208664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spironolactone has antiarrhythmic activity in ischaemic cardiac patients without cardiac failure.
    Shah NC; Pringle SD; Donnan PT; Struthers AD
    J Hypertens; 2007 Nov; 25(11):2345-51. PubMed ID: 17921831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
    Isnard R; Pousset F; Chafirovskaïa O; Carayon A; Hulot JS; Thomas D; Komajda M
    Am Heart J; 2003 Oct; 146(4):729-35. PubMed ID: 14564330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure.
    Tsutamoto T; Wada A; Maeda K; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Sawaki M; Fujii M; Matsumoto T; Matsui T; Kinoshita M
    J Am Coll Cardiol; 2001 Apr; 37(5):1228-33. PubMed ID: 11300427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure.
    Bauersachs J; Fraccarollo D
    Minerva Cardioangiol; 2003 Apr; 51(2):155-64. PubMed ID: 12783071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Value of plasma brain natriuretic peptide detection in cardiac function assessment in hemodialysis patients].
    Shao YH; Lai YQ; Lin AZ; Kong YZ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jul; 25(7):892-4. PubMed ID: 16027094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of angiotensin converting enzyme inhibitor with different doses on plasma brain natriuretic peptide and norepinephrine in patients with chronic heart failure].
    Song HM; Zhang J; Deng B; Luo M
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(25):1737-40. PubMed ID: 16253158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between aldosterone, oxidative stress, and inflammation in chronic, stable human heart failure.
    Kotlyar E; Vita JA; Winter MR; Awtry EH; Siwik DA; Keaney JF; Sawyer DB; Cupples LA; Colucci WS; Sam F
    J Card Fail; 2006 Mar; 12(2):122-7. PubMed ID: 16520260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of treatment of arrhythmias requiring therapy in dilated cardiomyopathy with amiodarone on alpha human atrial natriuretic peptide].
    Zirm B; Zirm A; Kargl R; Hartter E
    Acta Med Austriaca; 1992; 19(3):83-7. PubMed ID: 1414168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
    van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA
    Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible vascular role of increased plasma arginine vasopressin in congestive heart failure.
    Nakamura T; Funayama H; Yoshimura A; Tsuruya Y; Saito M; Kawakami M; Ishikawa SE
    Int J Cardiol; 2006 Jan; 106(2):191-5. PubMed ID: 16321691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-6 and B-type natriuretic peptide are independent predictors for worsening of heart failure in patients with progressive congestive heart failure.
    Gwechenberger M; Hülsmann M; Berger R; Graf S; Springer C; Stanek B; Pacher R
    J Heart Lung Transplant; 2004 Jul; 23(7):839-44. PubMed ID: 15261178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Changes in aldosterone receptors in congestive heart disease. Report of a case].
    Sánchez G; Posadas C; Boyer JL; Guzmán J; Serrano P
    Arch Inst Cardiol Mex; 1980; 50(4):461-9. PubMed ID: 7469590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neurohormonal activation in congestive heart failure: does it normalize after heart transplantation?].
    Pérez-Villa F; Roig E; Ferrer E; Cuppoletti A; Llancaqueo M; Jiménez W; Sanz G
    Rev Esp Cardiol; 2004 Aug; 57(8):725-31. PubMed ID: 15282060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The level of plasma neuroendocrine activity and the concentration of digoxin in the serum of patients with mild chronic heart failure.
    Jablecka A; Chmara E; Korzeniowska K
    Int J Clin Pharmacol Res; 1998; 18(4):171-8. PubMed ID: 10052027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spironolactone use in patients with heart failure.
    Trujillo JM; Gonyeau MJ; DiVall MV; Alexander SL
    J Clin Pharm Ther; 2004 Apr; 29(2):165-70. PubMed ID: 15068406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fracture risk in men with congestive heart failure risk reduction with spironolactone.
    Carbone LD; Cross JD; Raza SH; Bush AJ; Sepanski RJ; Dhawan S; Khan BQ; Gupta M; Ahmad K; Khouzam RN; Dishmon DA; Nesheiwat JP; Hajjar MA; Chishti WA; Nasser W; Khan M; Womack CR; Cho T; Haskin AR; Weber KT
    J Am Coll Cardiol; 2008 Jul; 52(2):135-8. PubMed ID: 18598893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
    Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M
    Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.